Why DCGO Stock dropped -9.59% Today — RQD Quant Desk Flash

Per the Roarable RQD rating, DCGO scores 41 out of 100, earning a D- grade and the verdict "Roarable Sell — Vulnerable Balance Sheet & Flow." Across its five pillars: the Fundamental Cash Engine scores 8/20 (ROIC -35%; FCF yield 0%), indicating the business is not currently converting capital into returns. Whale 13F Flow scores 11/20 (institutional accumulation and options positioning), the strongest pillar but still below midpoint. Insider Conviction scores 5/20 (SEC Form 4 and Congressional PTR cluster flow), the weakest signal in the rating. Macro Regime Fit scores 9/20 (Beta 1.0; sector sensitivity). Forensic Balance Sheet scores 8/20 (Altman Z 0.2; Piotroski F 5/9; Debt/Equity 0.5).

For a prospective investor, the rating points to elevated fundamental and balance-sheet risk. The upside case rests mainly on institutional flow and any recovery in cash generation, which the source data does not establish as already underway. Valuation cannot be framed through earnings multiples because P/E and EV/EBITDA are unavailable in the source data, so the investor would have to weigh a $27.0M market capitalization against a reported FY 2025 net loss and negative ROIC without a standard earnings-based reference point. This is an educational reading of the rating, not personalized financial advice.

Per the SEC financials, revenue fell from $616.6M in FY 2024 to $322.2M in FY 2025, and operating income moved from $28.7M to $-178.0M. Per the market data, operating margin is -55.3%, net margin is -60%, and gross margin is 0%. ROIC is -35%. Per the Roarable RQD rating, the Altman Z-Score is 0.2, the Piotroski F-Score is 5/9, and Debt/Equity is 0.5. Cash of $51.0M against debt of $0.2M is reported for FY 2025, though the forensic Debt/Equity figure is not reconciled to these balances in the source data.

Per the recent news and catalysts section, the most material items are debt-related. One report describes DocGo securing up to $102M in term loans at SOFR+7.5% with 4M warrants issued and the Citi revolver terminated. A related Minichart item describes amending the credit facility to raise term loans to $102.5M with the same 4M warrants. Both are rated YELLOW under the source's impact labeling. Remaining items are market-action reports (price ticks toward $0.28 resistance, exhaustion-gap, rectangle-pattern and dark-pool references) from aggregator sources, with no fundamental content beyond price behavior. Per the Butterfly Supply-Chain Graph, no supply chain is mapped and no proprietary signals are listed. Watch items: financing terms at SOFR+7.5%, warrant dilution from the 4M warrants, and the revolver termination.

• What drove the revenue decline from $616.6M to $322.2M between FY 2024 and FY 2025, and is it recurring?
• What are the covenant and maturity terms of the $102.5M term loans, and how do the 4M warrants affect dilution?
• Why does the FY 2023 cash and debt data show N/A, and how does the FCF of $-64.5M reconcile with later years?
• How does the profile's $0.0B market capitalization reconcile with the $27.0M figure in market data?
• What is the composition of 13F and insider flow behind the 11/20 and 5/20 pillar scores?